About Histogenics Corporation
Histogenics was acquired by Ocugen, (Nasdaq: OCGN) on September 27, 2019.
Histogenics (Nasdaq: HSGX) is a leader in personalized restorative cell therapies (RCT) for active living. Our first investigational product candidate, NeoCart® is a proprietary RCT that rebuilds a patient’s own knee cartilage, treating pain at the source and potentially preventing progression to osteoarthritis (OA).
Read our community guidelines: https://goo.gl/Qtusgh
|
|
|
1-10 employees
View all Histogenics Corporation employees
|
|
Biotechnology
|
|
Waltham, MA 02451, US
|
|
2000
|
|
Regenerative Medicine, Tissue Engineering, Cartilage Regeneration And Repair, Musculoskeletal And Orthopaedics
|
Histogenics Corporation Alternatives
Histogenics Corporation Staff Directory
Search Histogenics Corporation Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
